Showing results (21-30 of 105) with videos related to
Sort By:
Pageof 11
Pharmacoeconomics|October 20, 2022
Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment ArrangementAmy Gye, Stephen Goodall, Richard De Abreu LourencoNew South Wales Public Health Bulletin|June 3, 2011
An economic evaluation of community and residential aged care falls prevention strategies in NSWJody Church, Stephen Goodall, Richard Norman, et al.Social Science & Medicine (1982)|March 9, 2020
The knowledge and attitude of Ghanaian decision-makers and researchers towards health technology assessmentRebecca Addo, Jane Hall, Marion Haas, et al.International Journal of Technology Assessment in Health Care|September 28, 2020
Assessing the capacity of Ghana to introduce health technology assessment: a systematic review of economic evaluations conducted in GhanaRebecca Addo, Stephen Goodall, Jane Hall, et al.International Journal of Technology Assessment in Health Care|June 14, 2023
A systematic review of economic evaluations for <i>RPE65</i>-mediated inherited retinal disease including HTA assessment of broader valueMaria Farris, Stephen Goodall, Richard De Abreu LourencoValue in Health Regional Issues|April 2, 2018
Cost Effectiveness of a Community-Delivered Consultation to Improve Infant Sleep Problems and Maternal Well-BeingSopany Saing, Bonny Parkinson, Jody Church, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
A Systematic Review of Health Technology Assessments of Chimeric Antigen Receptor T-Cell Therapies in Young Compared With Older PatientsAmy Gye, Stephen Goodall, Richard De Abreu LourencoPharmacoeconomics - Open|April 23, 2021
Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility AnalysisHansoo Kim, Greg Cook, Stephen Goodall, et al.Pharmacoeconomics|September 7, 2024
Different Models, Same Results: Considerations When Choosing Between Approaches to Model Cost Effectiveness of Chimeric-Antigen Receptor T-Cell Therapy Versus Standard of CareAmy Gye, Richard De Abreu Lourenco, Stephen GoodallDiseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 5, 2024
Factors influencing the cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia in AustraliaLauren Caush, Jody Church, Stephen Goodall, et al.Pageof 11